”Cutting the time to approve a drug by one week can mean saving one million euro or more”
The road to approving a new drug is cumbersome. Clinical trials are extensive, detailed research studies which test the safety and efficacy of a drug. Actelion Pharmaceuticals conducts clinical trials the world over using Anoto digital pen and paper to record data for 12 trials throughout the Western Europe, the United States, Australia and Israel.
Over the past 25 years the average cost to develop a new drug has jumped from $138 to $802 million. For the pharmaceutical companies like Actelion, every successful effort to improve efficiency and quality directly contributes to continued competitiveness of the company and can be measured in realized revenue. ”Cutting the time to approve a
drug by one week can mean saving one million euro or more.” says Mr. Raineri.
Benefits:
- Easily deployed
- Very well received/accepted by trial study doctors
- Ensures traceability of collected data
- Reduces the time a drug takes to get to market which may represent millions of euro in earned revenue